Compounds > alizarin
Page last updated: 2024-08-17

alizarin and Carcinoma, Hepatocellular

alizarin has been researched along with Carcinoma, Hepatocellular in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bo, H; Liang, S; Zhang, Y; Zhen, H; Zhong, L1

Other Studies

1 other study(ies) available for alizarin and Carcinoma, Hepatocellular

ArticleYear
Alizarin, an Agonist of AHR Receptor, Enhances CYP1A1 Enzyme Activity and Induces Transcriptional Changes in Hepatoma Cells.
    Molecules (Basel, Switzerland), 2023, Oct-31, Volume: 28, Issue:21

    Topics: Carcinoma, Hepatocellular; Cell Line; Cytochrome P-450 CYP1A1; Humans; Molecular Docking Simulation; Receptors, Aryl Hydrocarbon

2023